Grundinformationen
- Standard-SMILES
CCCC/C=C\CCCCCCCC(=O)O- InChIKey
YWWVWXASSLXJHU-WAYWQWQTSA-N- Summenformel
- C14H26O2
- Durchschnittliche Molmasse
- 226,35 g/mol
- Monoisotopische Masse
- 226,19328007
Überblick
Myristoleic acid is a tetradecenoic acid in which the double bond is at the 9-10 position and has Z configuration. Myristoleic acid has been isolated from Serenoa repens and has cytotoxic and apoptosis-inducing effects. It has a role as an apoptosis inducer, a plant metabolite and an EC 3.1.1.1 (carboxylesterase) inhibitor. It is a long-chain fatty acid and a tetradecenoic acid. It is a conjugate acid of a myristoleate.
Namen und Bezeichner
- Bevorzugter Name
- Myristoleic Acid
- IUPAC
- (Z)-tetradec-9-enoic acid
- Lokaler Name
- (Z)-Tetradec-9-ensure
- Englischer Name
- MYRISTOLEIC ACID
- Summenformel
- C14H26O2
- Molmasse
- 226.35
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
544-64-9- PubChem CID
- 5281119
- DTXSID
DTXSID5041568- ChEMBL
CHEMBL456732- ChEBI
CHEBI:27781- UNII
- RF23WGD123
- EC Number
- 208-876-8
- Nikkaji
- J11.362J
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 5,1
- Polarare Oberfläche (TPSA)
- 37,3 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 11
- Schwere Atome
- 16
- Formalladung
- 0
- Komplexität
- 185
Experimentelle und physikochemische Eigenschaften
Lipids
Lipids -> Unambiguous Lipids
Fatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Unsaturated fatty acids [FA0103]
Physical Description
Liquid
Liquid
Physikochemische Eigenschaften
- Schmelzpunkt
- 4.5 · −4.5-−4 °C(lit.)
- Siedepunkt
- 144 °C0.6 · 144 °C0.6 mm Hg(lit.)
- Dichte
- 0.9 g/mL · 0.9 g/mL at 25 °C(lit.)
- Brechungsindex
- 20 · n20/D 1.4562(lit.)
- Flammpunkt
- 62 °C · 62 °C
- storage temp.
- -20 °C · -20°C
- Löslichkeit
- Benzene (Slightly), Chloroform (Slightly), Methanol (Slightly)
- Aggregatzustand
- Liquid
- pka
- 4.78 · 4.78±0.10(Predicted)
- Farbe
- Colourless
- Biologische Quelle
- plant
- InChI
- InChI=1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5-
- InChIKey
- YWWVWXASSLXJHU-WAYWQWQTSA-N
- SMILES
- C(O)(=O)CCCCCCC/C=C\CCCC
- LogP
- 5.383 · 5.383 (est)
- EPA chemische Informationen
- 9 · 9-Tetradecenoic acid, (9Z)- (544-64-9)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 82.1% (569 of 693) of all reports.
Warning
H315 (13.9%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 693 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Regulatory Information
9-Tetradecenoic acid, (9Z)- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 9-Tetradecenoic acid, (9Z)- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
9-Tetradecenoic acid, (9Z)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Sicherheitsdaten
- wgk
- 3
- tsca
- TSCA listed
- ridadr
- NA 1993 / PGIII
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 26-36
- Speicherklasse
- 10 - Combustible liquids
- Hazard Classifications
- Eye Irrit. 2Skin Irrit. 2STOT SE 3
Chemie und Industrie
Pharmakologische Informationen
Verwendung und Herstellung
Use Classification
EPA Safer Chemical Functional Use Classes -> Surfactants
Safer Chemical Classes -> Green circle - The chemical has been verified to be of low concern
General Manufacturing Information
Plastics Product Manufacturing
9-Tetradecenoic acid, (9Z)-: ACTIVE
Anwendungen
VerwendenMyristoleic Acid induces apoptosis and necrosis in human prostrate cancer cell LNCaP, and is of a potential for developing an attractive new tool for the treatment of prostrate cancer.
Vor- und nachgelagerte Produkte
Nachgelagerte Produkte
Anbieter50 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…